E-viri
PDF
Recenzirano
Odprti dostop
-
Klein, Allan L; Imazio, Massimo; Cremer, Paul; Brucato, Antonio; Abbate, Antonio; Fang, Fang; Insalaco, Antonella; LeWinter, Martin; Lewis, Basil S; Lin, David; Luis, Sushil A; Nicholls, Stephen J; Pano, Arian; Wheeler, Alistair; Paolini, John F
The New England journal of medicine, 01/2021, Letnik: 384, Številka: 1Journal Article
Patients with recurrent pericarditis were treated with the interleukin-1 trap rilonacept. Those who had a response were randomly assigned to receive continued rilonacept or placebo. Rilonacept led to a significantly lower risk of pericarditis recurrence than placebo.
